CTOs on the Move

Curaytor

www.curaytor.com

 
Curaytor is an exclusive real estate marketing and advertising solution that helps listing agents attract more listings.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

NewAge

NewAge is a purpose-driven firm dedicated to inspiring the planet to Live Healthy™. Colorado-based NewAge commercializes a portfolio of organic and healthy products worldwide through primarily a direct-to-consumer (D2C) route to market distribution system across more than 75 countries. The company competes in three major category platforms: Health + Wellness, Inner + Outer Beauty and Nutritional Performance + Weight Management — leading a network of more than 400,000 exclusive independent Brand Partners, empowered with the leading social selling tools and technology around the world.

HiMama

HiMama is an all-in-one daycare app that provides parent messaging, daily reports, check-in, and more. It offers childcare management made easy, empowering teachers and engaging parents. HiMama enables child care programs and parents to connect through...

Trilliant

We help deploy a broad set of smart grid initiatives such as advanced metering, distribution automation, demand response and distributed energy resources.

Workscape, A div. of ADP

Workscape Inc., A div. of ADP is a Marlborough, MA-based company in the Software and Internet sector.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.